Sientra to Participate in Upcoming Investor Conferences


SANTA BARBARA, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that its management team will participate in the following upcoming investor conferences:

Event:Stephens 2019 Nashville Investment Conference
Format:Fireside Chat and 1x1 Meetings
Date:Wednesday, November 13, 2019
Time: 11:15am CT
  
Event:Stifel 2019 Healthcare Conference
Format:Fireside Chat and 1x1 Meetings
Date:Wednesday, November 20, 2019
Time:8:35 am ET
  
Event: Canaccord Genuity MedTech & Diagnostics Forum
Format:1x1 Meetings
Date:Thursday, November 21, 2019
  

Audio webcasts of the fireside chats will be available on the investor relations section of Sientra’s web site at www.sientra.com. Replays of the webcast will be available for 90 days.

About Sientra

Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes.   The Company’s Breast Products Segment includes its OPUS™ breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology,  and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*).  The Company’s miraDry Segment comprises its miraDry® system, which is approved for sale in over 40 international markets, and is the only non-invasive FDA-cleared device for the permanent reduction of underarm sweat, odor and hair of all colors.
____________________
(*) Data on file

CONTACT: Investor Relations
805-679-8885

Kontaktdaten